Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Breast Cancer, Endocrine Therapy Initiation, and Early Metabolic Health Changes: a Prospective Follow-up Study

NCT06623903 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT06623903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06623903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Breast Cancer, Endocrine Therapy Initiation, and Early Metabolic Health Changes: a Prospective Follow-up Study
Lead sponsor
Aarhus University Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
November 1, 2024
Completion date
July 31, 2025
Enrollment
112 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early breast cancer, estrogen receptor positive breast cancer, metabolic health